Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-08-22 11:40 am Purchase | 13G | 1847 HLDGS LLC COM NO PAR EFSH | Strategic Risk LLC. | 4,000,000 9.800% | 41,576 (+1.05%) | View |
2023-08-21 4:49 pm Purchase | 13G | 1847 HLDGS LLC COM NO PAR EFSH | Strategic Risk LLC. | 3,958,424 9.700% | 792,573 (+25.04%) | View |
2023-07-17 09:00 am Purchase | 13G | 1847 HLDGS LLC COM NO PAR EFSH | Strategic Risk LLC. | 3,165,851 19.700% | 102,590 (+3.35%) | View |
2023-07-10 1:06 pm Purchase | 13G | 1847 HLDGS LLC COM NO PAR EFSH | Strategic Risk LLC. | 3,063,261 19.000% | 445,987 (+17.04%) | View |
2023-07-05 12:39 pm Purchase | 13G | 1847 HLDGS LLC COM NO PAR EFSH | Strategic Risk LLC. | 2,617,274 16.000% | 2,105,292 (+411.20%) | View |
2023-06-16 11:17 am Purchase | 13G | 1847 HLDGS LLC COM NO PAR EFSH | Strategic Risk LLC. | 511,982 7.800% | 511,982 (New Position) | View |
2023-03-28 3:30 pm Unchanged | 13G | NEUROBO PHARMACEUTICALS INC CO NRBO | Strategic Risk LLC. | 1,202,833 6.300% | 0 (Unchanged) | View |
2023-03-28 12:34 pm Unchanged | 13G | MYOMO INC. MYO | Strategic Risk LLC. | 1,057,279 5.100% | 0 (Unchanged) | View |
2023-03-27 4:36 pm Purchase | 13G | Strategic Risk LLC. MYO | Strategic Risk LLC. | 1,202,833 6.300% | 1,202,833 (New Position) | View |
2023-03-27 4:30 pm Purchase | 13G | Strategic Risk LLC. MYO | Strategic Risk LLC. | 1,057,279 5.100% | 1,057,279 (New Position) | View |